Assembly Bill A3833

2025-2026 Legislative Session

Relates to capping cost sharing for antiviral COVID-19 therapeutics

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

2025-A3833 (ACTIVE) - Details

See Senate Version of this Bill:
S6925
Current Committee:
Assembly Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L
Versions Introduced in 2023-2024 Legislative Session:
A9662, S8367

2025-A3833 (ACTIVE) - Summary

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

2025-A3833 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   3833
 
                        2025-2026 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 30, 2025
                                ___________
 
 Introduced by M. of A. WEPRIN -- read once and referred to the Committee
   on Insurance
 
 AN  ACT  to  amend  the  insurance  law  and the social services law, in
   relation to capping cost sharing for antiviral COVID-19 therapeutics
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.    Subsection  (i) of section 3216 of the insurance law is
 amended by adding a new paragraph 40 to read as follows:
   (40) (A) EVERY POLICY THAT PROVIDES COVERAGE  FOR  PRESCRIPTION  DRUGS
 SHALL  PROVIDE  COVERAGE  FOR ANTIVIRAL THERAPEUTICS APPROVED OR GRANTED
 EMERGENCY USE AUTHORIZATION BY THE FOOD AND DRUG ADMINISTRATION FOR  THE
 TREATMENT OF COVID-19 WHEN PRESCRIBED BY A LICENSED HEALTH CARE PROVIDER
 LEGALLY AUTHORIZED TO PRESCRIBE UNDER TITLE EIGHT OF THE EDUCATION LAW.
   (B)  COVERAGE  UNDER  THIS  PARAGRAPH  SHALL  NOT BE SUBJECT TO ANNUAL
 DEDUCTIBLES OR COINSURANCE, PROVIDED, HOWEVER, THAT AN  INSURED  WHO  IS
 ELIGIBLE  FOR AND ABLE TO OBTAIN PRESCRIBED ANTIVIRAL THERAPEUTICS AT NO
 COST OR REDUCED COST UNDER A MANUFACTURER OR GOVERNMENT PROGRAM  MAY  BE
 REQUIRED  TO USE SUCH PROGRAM BEFORE USING COVERAGE REQUIRED PURSUANT TO
 THIS PARAGRAPH.
   § 2. Subsection (k) of section 3221 of the insurance law is amended by
 adding a new paragraph 24 to read as follows:
   (24) (A) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR  DELIV-
 ERY  IN  THIS  STATE THAT PROVIDES COVERAGE FOR PRESCRIPTION DRUGS SHALL
 PROVIDE COVERAGE FOR ANTIVIRAL THERAPEUTICS APPROVED OR GRANTED EMERGEN-
 CY USE AUTHORIZATION BY THE FOOD AND DRUG ADMINISTRATION FOR THE  TREAT-
 MENT  OF  COVID-19  WHEN  PRESCRIBED  BY A LICENSED HEALTH CARE PROVIDER
 LEGALLY AUTHORIZED TO PRESCRIBE UNDER TITLE EIGHT OF THE EDUCATION LAW.
   (B) COVERAGE UNDER THIS PARAGRAPH  SHALL  NOT  BE  SUBJECT  TO  ANNUAL
 DEDUCTIBLES  OR  COINSURANCE,  PROVIDED, HOWEVER, THAT AN INSURED WHO IS
 ELIGIBLE FOR AND ABLE TO OBTAIN PRESCRIBED ANTIVIRAL THERAPEUTICS AT  NO
 COST  OR  REDUCED COST UNDER A MANUFACTURER OR GOVERNMENT PROGRAM MAY BE
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD07443-01-5
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.